Gracell Biotechnologies Inc ADR (NASDAQ: GRCL): Reassessing Prospects
Gracell Biotechnologies Inc ADR (GRCL) concluded trading on Wednesday at a closing price of $10.25, with 6.42 million shares of worth about $65.77 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 222.33% during that period and on Wednesday the price saw a gain […]
Gracell Biotechnologies Inc ADR (GRCL): Street Finally Waking Up
Logos Global Management LP recently announced the acquisition of new stake in Gracell Biotechnologies Inc ADR (NASDAQ:GRCL). The institutional investor has increased its shareholding in the Healthcare company by 40.28% to 2.52 million shares with purchase of 0.72 million shares. This fresh investment now brings its stake to 2.63% valued currently at $12.3 million. In […]
